New and Innovative Treatments
Concurrent Session 8
Time: 8:45 AM to 10:15 AM
Description
Moderators |
Ji Hyeon Ju Magali Cucchiarini |
8:45 AM - 9:25 AM |
Role of Neural Crest Derived Cells (NCC) in Limb Regeneration of Regenerative Model Species Farida Djouad |
9:25 AM - 9:35 AM |
077: APOPTOTIC BODY-INSPIRED NANOTHERAPEUTICS TARGET BRD4-REGULATED SYNOVIAL MACROPHAGE TO ATTENUATE OSTEOARTHRITIS Huan-Tian Zhang |
9:35 AM - 9:45 AM |
078: SELECTION OF AN APTAMER EXHIBITING HIGH AFFINITY FOR HEALTHY VERSUS OSTEOARTHRITIC HUMAN CHONDROCYTES Huaizhi Chen |
9:45 AM - 9:55 AM |
079: DECELLULARIZED CARTILAGE EXTRACELLULAR MATRIX AS MULTIFACETED VISCOSUPPLEMENT FOR OSTEOARTHRITIS. Eun Je Jeon |
9:55 AM - 10:05 AM |
080: COLLAGEN TARGETING NANOMICELLE WITH HIGH PENETRATION AND RETENTION IN CARTILAGE FOR IMPROVED TREATMENT OF OSTEOARTHRITIS Saptomee Chakraborty |
10:05 AM - 10:07 AM |
081: MAGNETIC NANOEMULSIONS AS INTRAARTICULAR THERAPEUTIC STRATEGY FOR OSTEOARTHRITIS: IN VITRO AND IN VIVO FINDINGS Luminita Labusca |
10:07 AM - 10:09 AM |
082: TARGETING NLRP3/NLRP1 INFLAMMASOMES: PRECLINICAL EFFICACY AND SAFETY OF INV-1498 FOR OSTEOARTHRITIS Yurim Lee |
10:09 AM - 10:11 AM |
083: INTERLEUKIN 11 AS A NOVEL TARGET FOR ARTHROFIBROSIS THERAPY Miguel Angel De Jesus |
10:11 AM - 10:13 AM |
084: ADENOSINE AND GUANOSINE-BASED OLIGONUCLEOTIDE ATTENUATES CATABOLIC PHENOTYPES IN CHONDROCYTES AND SLOWS PROGRESSION OF SURGICALLY INDUCED OSTEOARTHRITIS Yoonhee Kim |
10:13 AM - 10:15 AM | Q & A |